Interestingly, given the difference of tumour growth rate and PD-L1 expression between the two subtypes, the antigen intensity required for ER+ breast cancer is higher than that for TNBC and becomes similar to the starting tumour size increases. The gene discussed is CD274; the disease is breast carcinoma.